{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T04:20:06Z","timestamp":1727410806845},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,26]]},"DOI":"10.7759\/cureus.70233","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T08:05:14Z","timestamp":1727337914000},"source":"Crossref","is-referenced-by-count":0,"title":["Multiple Oral Manifestations in a Patient With Chronic Graft Versus Host Disease: A Case Report"],"prefix":"10.7759","author":[{"given":"Duo","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yidan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weilian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangjian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2033122","article-title":"Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease","volume":"385","author":"Zeiser R","year":"2021","unstructured":"Zeiser R, Polverelli N, Ram R, et al.. Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease. N Engl J Med. 2021, 385:228-38. 10.1056\/NEJMoa2033122","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgz007","article-title":"Oral complications of chronic graft-versus-host disease","volume":"2019","author":"Fall-Dickson JM","year":"2019","unstructured":"Fall-Dickson JM, Pavletic SZ, Mays JW, Schubert MM. Oral complications of chronic graft-versus-host disease. J Natl Cancer Inst Monogr. 2019, 2019:10.1093\/jncimonographs\/lgz007","journal-title":"J Natl Cancer Inst Monogr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-290403","article-title":"Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new","volume":"117","author":"Coghill JM","year":"2011","unstructured":"Coghill JM, Sarantopoulos S, Moran TP, Murphy WJ, Blazar BR, Serody JS. Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new. Blood. 2011, 117:3268-76. 10.1182\/blood-2010-12-290403","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2022.903154","article-title":"Oral chronic graft-versus-host disease","volume":"3","author":"Dean D","year":"2022","unstructured":"Dean D, Sroussi H. Oral chronic graft-versus-host disease. Front Oral Health. 2022, 3:903154. 10.3389\/froh.2022.903154","journal-title":"Front Oral Health"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2022.102612","article-title":"Improvement of chronic GVHD after oral treatment with Clostridium butyricum (Miya BM)","volume":"76","author":"Kaya H","year":"2022","unstructured":"Kaya H, Okumura H, Ishizawa S. Improvement of chronic GVHD after oral treatment with Clostridium butyricum (Miya BM). Anaerobe. 2022, 76:102612. 10.1016\/j.anaerobe.2022.102612","journal-title":"Anaerobe"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235775","article-title":"Oral cancer in HSCT pediatric patients arising on GVHD: a comprehensive review","volume":"14","author":"Cantile T","year":"2022","unstructured":"Cantile T, Coppola N, Canfora F, Adamo D, Ruoppo E, Mignogna MD, Leuci S. Oral cancer in HSCT pediatric patients arising on GVHD: a comprehensive review. Cancers (Basel). 2022, 14:10.3390\/cancers14235775","journal-title":"Cancers (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092175","article-title":"Secondary oral cancer after systemic treatment of hematological malignancies and oral GVHD: a systematic review","volume":"14","author":"Janowiak-Majeranowska A","year":"2022","unstructured":"Janowiak-Majeranowska A, Osowski J, Mikaszewski B, Majeranowski A. Secondary oral cancer after systemic treatment of hematological malignancies and oral GVHD: a systematic review. Cancers (Basel). 2022, 14:10.3390\/cancers14092175","journal-title":"Cancers (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1151493","article-title":"Perspectives on oral chronic graft-versus-host disease from immunobiology to morbid diagnoses","volume":"14","author":"Tollemar V","year":"2023","unstructured":"Tollemar V, Garming Legert K, Sugars RV. Perspectives on oral chronic graft-versus-host disease from immunobiology to morbid diagnoses. Front Immunol. 2023, 14:1151493. 10.3389\/fimmu.2023.1151493","journal-title":"Front Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12812","article-title":"Oral chronic graft-versus-host disease in Australia: clinical features and challenges in management","volume":"45","author":"Hull K","year":"2015","unstructured":"Hull K, Kerridge I, Avery S, McCullough M, Ritchie D, Szer J. Oral chronic graft-versus-host disease in Australia: clinical features and challenges in management. Intern Med J. 2015, 45:702-10. 10.1111\/imj.12812","journal-title":"Intern Med J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1590\/0103-6440201300200","article-title":"cGVHD-related caries and its shared features with other 'dry-mouth'-related caries","volume":"26","author":"Santos-Silva AR","year":"2015","unstructured":"Santos-Silva AR, Feio Pdo S, Vargas PA, Correa ME, Lopes MA. cGVHD-related caries and its shared features with other 'dry-mouth'-related caries. Braz Dent J. 2015, 26:435-40. 10.1590\/0103-6440201300200","journal-title":"Braz Dent J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5070\/D32612051360","article-title":"Lichenoid sialadenitis in chronic graft versus host disease","volume":"26","author":"Piacenza F","year":"2020","unstructured":"Piacenza F, Monteiro de Souza M, Ducati Dabronzo ML, Batista Bologna S, Menta Simonsen M, Louren\u00e7o SV. Lichenoid sialadenitis in chronic graft versus host disease. Dermatol Online J. 2020, 26:13030\/qt7wp6t39z. 10.5070\/D32612051360","journal-title":"Dermatol Online J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-021-06392-6","article-title":"Oral white lesion in patients post-hematopoietic stem cell transplantation: a case series demonstrating the diagnostic dilemma","volume":"29","author":"Pukhalskaya T","year":"2021","unstructured":"Pukhalskaya T, Smoller BR, Becker M, Maly A, Zadik Y, Elad S. Oral white lesion in patients post-hematopoietic stem cell transplantation: a case series demonstrating the diagnostic dilemma. Support Care Cancer. 2021, 29:7999-8007. 10.1007\/s00520-021-06392-6","journal-title":"Support Care Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2011.77","article-title":"Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes","volume":"46","author":"Mawardi H","year":"2011","unstructured":"Mawardi H, Elad S, Correa ME, et al.. Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes. Bone Marrow Transplant. 2011, 46:884-91. 10.1038\/bmt.2011.77","journal-title":"Bone Marrow Transplant"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.60147","article-title":"Late presentation of oral chronic graft versus host disease manifesting as hyperkeratotic plaque: a case report","volume":"16","author":"Felemban MF","year":"2024","unstructured":"Felemban MF, AlRasheed RS, Alshagroud RS, Aldosari AM. Late presentation of oral chronic graft versus host disease manifesting as hyperkeratotic plaque: a case report. Cureus. 2024, 16:e60147. 10.7759\/cureus.60147","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200767080-00006","article-title":"Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review","volume":"67","author":"Gutierrez-Dalmau A","year":"2007","unstructured":"Gutierrez-Dalmau A, Campistol JM. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs. 2007, 67:1167-98. 10.2165\/00003495-200767080-00006","journal-title":"Drugs"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2016.00150","article-title":"Reduced CX3CL1 secretion contributes to the susceptibility of oral leukoplakia-associated fibroblasts to Candida albicans","volume":"6","author":"Cheng R","year":"2016","unstructured":"Cheng R, Li D, Shi X, et al.. Reduced CX3CL1 secretion contributes to the susceptibility of oral leukoplakia-associated fibroblasts to Candida albicans. Front Cell Infect Microbiol. 2016, 6:150. 10.3389\/fcimb.2016.00150","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/294805-multiple-oral-manifestations-in-a-patient-with-chronic-graft-versus-host-disease-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T08:05:16Z","timestamp":1727337916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/294805-multiple-oral-manifestations-in-a-patient-with-chronic-graft-versus-host-disease-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.70233","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,26]]}}}